Anda belum login :: 23 Nov 2024 10:22 WIB
Detail
BukuPeranan Epigallokatekin-3-Gallat (EGCG) pada teh hijau sebagai terapi adjuvan bagi kanker payudara dengan reseptor estrogen (RE) negatif (studi kepustakaan)
Bibliografi
Author: ANTONI, IRENE ; Margaret, Ayly (Advisor); Hidayat, Jenny (Advisor); Lembar, Stefanus (Examiner)
Topik: BREAST CANCER; egcg; nnegative estrogen receptor breast cancer; serm; flavonoid; tamoxifen; green tea EGCG; negative ekstrogen receptor breast cancer; serm; flavonoid tamoxifen; green tea
Bahasa: (ID )    
Penerbit: Fakultas Kedokteran Unika Atma Jaya     Tempat Terbit: Jakarta Utara    Tahun Terbit: 2014    
Jenis: Theses - Karya Tulis Ilmiah Kedokteran (KTI-FK)
Fulltext: Irene_Antoni_KTI_2014.pdf (794.04KB; 1 download)
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: KTI-FK-512
    • Non-tandon: tidak ada
    • Tandon: 1
 Lihat Detail Induk
Abstract
Background: Female breast cancer comes second in Southeast Asia and represent 16% of all cancers. Breast cancer incidence been multiplying, although there’re no maximal effect of therapy found yet. Cancer’s treatment needs to be combined with EGCG consumption. EGCG is a green tea compound and known as adjuvant therapy for breast cancer.
Purpose: The purpose of this study is to gather information about EGCG’s work mechanism and recommended dose as adjuvant therapy for breast cancer.
Methods: Systematic review were used and using Springerlink, Google scholar, and proquest. The journals were from 2003 – 2013 and key words were EGCG, negative estrogen receptor breast cancer, SERM, flavonoid, tamoxifen, green tea. Critical appraisal used to check the quality of journals.
Results : 6 journals showed positive association between EGCG and breast cancer. EGCG’s roles are inducting re-expression of ER by histone modification, DNA methylation, inducting apoptosis and inhibiting cancer cell proliferation. Combination 10 µM EGCG with 100 ng/mL TSA and 20 µg/mL EGCG, 5 µM SFN and 2 µM 5-aza optimalized EGCG’s function.
Conclusion: EGCG a role as adjuvant therapy for negative estrogen receptor breast cancer by regulating epigenetic mechanism.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Lihat Sejarah Pengadaan  Konversi Metadata   Kembali
design
 
Process time: 0.1875 second(s)